FEBRUARY 16, 2012

Evaluating Preference Trials of Oral Phosphodiesterase 5 Inhibitors for Erectile Dysfunction

E-mail Print
Volume 49, Issue 1, Pages 30-37 (January 2006)

Abstract -

More treatment options are available now for the treatment of erectile dysfunction (ED) than ever. Treatments include oral phosphodiesterase 5 (PDE5) inhibitors, intracavernosal injections, vacuum constriction devices, and penile implants. Clinicians, researchers, and patients are interested in making direct comparisons between the response of newer treatments and that of established and more developed therapies.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |